Met Life Investment Management, LLC Rapt Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$6.87 - $26.45 $108,209 - $416,613	15,751 New	15,751 $141,000
Q2 2023 Apr 29, 2024	BUY	$16.06 - $21.61 $252,961 - $340,379	15,751 New	15,751 $294,000
Q1 2023 May 09, 2024	BUY	$17.19 - $30.8 $270,759 - $485,130	15,751 New	15,751 $289 Million
Q1 2023 May 15, 2023	BUY	$17.19 - $30.8 $33,451 - $59,936	1,946 Added 14.1%	15,751 $289,000
Q4 2022 Jun 14, 2023	SELL	$16.28 - $24.6 $31,680 - $47,871	-1,946 Reduced 12.35%	13,805 $273,000
Q3 2022 May 10, 2024	BUY	$17.96 - $30.46 $15,912 - $26,987	886 Added 6.86%	13,805 $332,000
Q3 2022 Jun 14, 2023	SELL	$17.96 - $30.46 $34,950 - $59,275	-1,946 Reduced 12.35%	13,805 $332,000
Q3 2022 Mar 22, 2023	BUY	$17.96 - $30.46 $15,912 - $26,987	886 Added 6.86%	13,805 $332,000
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $15,912 - $26,987	886 Added 6.86%	13,805 $332,000
Q2 2022 May 10, 2024	BUY	$10.26 - $23.59 $19,401 - $44,608	1,891 Added 17.15%	12,919 $235,000
Q2 2022 Jun 20, 2023	SELL	$10.26 - $23.59 $29,056 - $66,806	-2,832 Reduced 17.98%	12,919 $235,000
Q2 2022 Mar 22, 2023	BUY	$10.26 - $23.59 $19,401 - $44,608	1,891 Added 17.15%	12,919 $235,000
Q2 2022 Aug 11, 2022	BUY	$10.26 - $23.59 $19,401 - $44,608	1,891 Added 17.15%	12,919 $236,000
Q1 2022 May 10, 2024	BUY	$17.02 - $40.22 $187,696 - $443,546	11,028 New	11,028 $242,000
Q1 2022 Jun 20, 2023	SELL	$17.02 - $40.22 $80,385 - $189,959	-4,723 Reduced 29.99%	11,028 $242,000
Q1 2022 Mar 22, 2023	BUY	$17.02 - $40.22 $69,271 - $163,695	4,070 Added 58.49%	11,028 $242,000
Q1 2022 May 12, 2022	BUY	$17.02 - $40.22 $69,271 - $163,695	4,070 Added 58.49%	11,028 $243,000
Q4 2021 Jun 21, 2023	SELL	$29.5 - $39.5 $259,393 - $347,323	-8,793 Reduced 55.83%	6,958 $255,000
Q3 2021 Jun 21, 2023	SELL	$29.86 - $39.47 $262,558 - $347,059	-8,793 Reduced 55.83%	6,958 $216,000
Q2 2021 May 17, 2024	SELL	$17.99 - $40.02 $158,186 - $351,895	-8,793 Reduced 55.83%	6,958 $221,000
Q2 2021 Jun 21, 2023	SELL	$17.99 - $40.02 $158,186 - $351,895	-8,793 Reduced 55.83%	6,958 $221,000
Q2 2021 Mar 22, 2023	BUY	$17.99 - $40.02 $29,089 - $64,712	1,617 Added 30.28%	6,958 $221,000
Q2 2021 Aug 16, 2021	BUY	$17.99 - $40.02 $125,174 - $278,459	6,958 New	6,958 $221,000
Q4 2020 Feb 16, 2021	SELL	$15.89 - $40.87 $84,868 - $218,286	-5,341 Closed	0 $0
Q3 2020 Jun 26, 2023	SELL	$21.6 - $37.5 $224,856 - $390,375	-10,410 Reduced 66.09%	5,341 $171,000
Q2 2020 May 24, 2024	SELL	$14.16 - $32.85 $147,405 - $341,968	-10,410 Reduced 66.09%	5,341 $155 Million
Q2 2020 Jun 26, 2023	SELL	$14.16 - $32.85 $147,405 - $341,968	-10,410 Reduced 66.09%	5,341 $154,000
Q2 2020 Mar 22, 2023	SELL	$14.16 - $32.85 $119,850 - $278,042	-8,464 Reduced 61.31%	5,341 $154,000
Q2 2020 Aug 14, 2020	BUY	$14.16 - $32.85 $75,628 - $175,451	5,341 New	5,341 $155,000

Others Institutions Holding RAPT

# of Institutions

105

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

Vanguard Group Inc Valley Forge, PA

3.16M
Shares

$3.79 Million
0.0% of portfolio
Column Group LLC San Francisco, CA

2.68M
Shares

$3.22 Million
7.75% of portfolio
Black Rock Inc. New York, NY

2.44M
Shares

$2.93 Million
0.0% of portfolio
Kingdon Capital Management, L.L.C. New York, NY

1.73M
Shares

$2.07 Million
0.42% of portfolio
Ponoi Management, LLC San Francisco, CA

1.6M
Shares

$1.92 Million
52.54% of portfolio

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $35.6M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account